$60.5 Million available via Pharmaceutical Benefit Plan Settlements
Overview
There are typically several active lawsuits and/or class action settlements that fall into the category of “pharmaceutical benefit plan settlements.” Under these cases, it is generally alleged that businesses with self-insured health plans overpaid for drugs purchased on behalf of their employees due to artificially inflated and/or stabilized prices.
The prices were allegedly manipulated as a result of anti-competitive practices undertaken by the drug manufacturers. The number of these opportunities in any given year varies, but there can be several available at the same time.
Immediately Available Settlement(s):
Effexor XR Settlement
Date Range: July 2008 - May 2011
Settlement Fund: $25.5 million
Filing Deadline: 9/16/2024
Settlement Overview: Wyeth has settled claims with end-payors after it was alleged they conspired to block generic versions of Effexor XR (antidepressant and nerve pain medication ) off the market, causing consumers and third-party payors to pay supra-competitive prices for the drug and its generic equivalents.
Eligible Locations: To be a member of the Settlement Class, you must have indirectly purchased, paid, and/or provided reimbursement for Effexor XR or AB-rated generic versions of Effexor XR, in Select States, not for resale.
Select States: Arizona, California, Florida, Kansas, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nevada, New Hampshire, New Mexico, New York, North Carolina, Oregon, Rhode Island, South Dakota, Tennessee, West Virginia, and Wisconsin.
Eligible Drugs: Effexor XR and/or its AB-rated generic version(s).
Lipitor Settlement
Date Range: June 2011 – December 2012
Settlement Fund: $35 million
Filing Deadline: 11/29/2024
Settlement Overview: Pfizer has reached a settlement with end payors over allegations that it colluded with Ranbaxy to delay the market entry of generic Lipitor, a cholesterol lowering medicine, resulting in end payors paying inflated prices for the drug and its generics.
Eligible Locations: To be a member of the Settlement Class, you must have indirectly purchased, paid and/or provided reimbursement for some or all of the purchase price of Branded Lipitor or generic atorvastatin, in Select States, not for resale.
Select States: Arizona, California, Washington, D.C., Florida, Iowa, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon, South Dakota, Tennessee, West Virginia, and Wisconsin.
Eligible Drugs: Branded Lipitor or generic atorvastatin.
Recommended Next Steps Data is often required to complete your claim for settlements in this category. Connect us with a member of your Benefits Department so an MCAG representative can describe the information that is necessary to complete your claim for these pharmaceutical settlements. We typically only need a 5 to 10 minute call. We will quickly review the process so we can efficiently obtain necessary information from your Pharmacy Benefit Manager (i.e. CVS Caremark, Express Scripts, OptumRX) to pursue current and future pharmaceutical settlements.
Eligible contracted clients can expect to be contacted by an MCAG representative to review and assist with gathering the necessary information for these settlements.
MCAG is not the Settlement/Class Administrator, and this is not an official settlement website.
Need more information? CLICK HERE to complete our contact form and an MCAG representative will respond shortly.
留言